Patent · US Active

CD80 variant immunomodulatory proteins and uses thereof

US11479609B2 · kind B2 · utility

0Cited by
98References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 2, 2022
Grant dateOct 25, 2022
Priority date—
Expiry dateFeb 2, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/03
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are variant CD80 polypeptides, immunomodulatory proteins comprising variant CD80 polypeptides, and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.